Chief Medical Officer

Dr Harmony Garges is our Chief Medical Officer. She is responsible for Regulatory, Safety and Medical Affairs. In 2005, Harmony joined the Infectious Diseases group at GSK and spent several years working on global development programmes, as project physician leader for Fosamprenavir, Valtrex and Altabax, leading to three successful NDA/MAA files for new or expanded indications. Harmony provided medical leadership and strategy for the development of various other anti-infectives through phases I to III, including the FTIH dolutegravir trial.

She then joined Global Clinical Safety & Pharmacovigilance, where she provided safety strategy and governance for several large global clinical development programmes in Pharma, and as Global VP of the Mature Products Safety Group, with accountability for the safety of over 500 marketed products across the Pharma and Consumer Healthcare (CH) portfolio. Harmony spent three years as the Chief Medical Officer for GSK's Consumer Healthcare business, where she was accountable for all aspects of product safety and medical governance for the global portfolio and led the medical organisation though the complex JV integration with Novartis.

Harmony graduated with high honours from Colgate University with a degree in Chemistry. She obtained her MD degree and completed her paediatrics residency at Duke University. Following a year as Chief Resident, she completed Paediatric Infectious Diseases and Medical Microbiology fellowships at Duke, along with her MPH in Epidemiology from the University of North Carolina at Chapel Hill.

Harmony is board-certified in General Paediatrics, Medical Microbiology and Paediatrics Infectious Diseases. Harmony is Adjunct Faculty at Duke, where she continues to provide patient care in the Duke Pediatric HIV/ clinic.

Follow Harmony on her LinkedIn page here.


Our Executive Team

Harmony Garges, Chief Medical Officer at ViiV Healthcare
Dr Harmony Garges

Chief Medical Officer

Read more
Kimberly Smith, Head of Research and Development, ViiV Healthcare
Dr Kimberly Smith

Head of Research and Development

Read more
Lynn Baxter, Head of North America, ViiV Healthcare
Lynn Baxter

Head of North America

Read more
Neil Wilkinson, Chief Financial Officer
Neil Wilkinson

Chief Financial Officer

Read more
Cheryl MacDiarmid, Head of Global Commercial Strategy, ViiV Healthcare
Cheryl MacDiarmid

Head of Global Commercial Strategy

Read more
Andrew Stewart, General Counsel and Chief Compliance Officer, ViiV Healthcare
Andrew Stewart

General Counsel and Chief Compliance Officer

Read more
Stephen Rea, Head of External Affairs and Communications ViiV Healthcare
Stephen Rea

Head of External Affairs and Communications

Read more
Lauren Carey, Head of International
Lauren Carey

Head of International

Read more


We are ViiV Healthcare: 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS.

Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.

Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.